309 related articles for article (PubMed ID: 30409838)
21. Interactions between gut bacteria and bile in health and disease.
Long SL; Gahan CGM; Joyce SA
Mol Aspects Med; 2017 Aug; 56():54-65. PubMed ID: 28602676
[TBL] [Abstract][Full Text] [Related]
22. Comprehensive evaluation of SCFA production in the intestinal bacteria regulated by berberine using gas-chromatography combined with polymerase chain reaction.
Wang LL; Guo HH; Huang S; Feng CL; Han YX; Jiang JD
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Jul; 1057():70-80. PubMed ID: 28505492
[TBL] [Abstract][Full Text] [Related]
23. The berberine-enriched gut commensal Blautia producta ameliorates high-fat diet (HFD)-induced hyperlipidemia and stimulates liver LDLR expression.
Yang YN; Wang QC; Xu W; Yu J; Zhang H; Wu C
Biomed Pharmacother; 2022 Nov; 155():113749. PubMed ID: 36174380
[TBL] [Abstract][Full Text] [Related]
24. The Effects of Berberine on the Gut Microbiota in Apc
Wang H; Guan L; Li J; Lai M; Wen X
Molecules; 2018 Sep; 23(9):. PubMed ID: 30205580
[No Abstract] [Full Text] [Related]
25. Transforming berberine into its intestine-absorbable form by the gut microbiota.
Feng R; Shou JW; Zhao ZX; He CY; Ma C; Huang M; Fu J; Tan XS; Li XY; Wen BY; Chen X; Yang XY; Ren G; Lin Y; Chen Y; You XF; Wang Y; Jiang JD
Sci Rep; 2015 Jul; 5():12155. PubMed ID: 26174047
[TBL] [Abstract][Full Text] [Related]
26. Cholesterol-lowering effect of bile salt hydrolase from a
Zhu H; Zhao F; Zhang W; Xia W; Chen Y; Liu Y; Fan Z; Zhang Y; Yang Y
Food Funct; 2022 Jan; 13(2):725-736. PubMed ID: 34935837
[TBL] [Abstract][Full Text] [Related]
27. FXR-Dependent Modulation of the Human Small Intestinal Microbiome by the Bile Acid Derivative Obeticholic Acid.
Friedman ES; Li Y; Shen TD; Jiang J; Chau L; Adorini L; Babakhani F; Edwards J; Shapiro D; Zhao C; Carr RM; Bittinger K; Li H; Wu GD
Gastroenterology; 2018 Dec; 155(6):1741-1752.e5. PubMed ID: 30144429
[TBL] [Abstract][Full Text] [Related]
28. Berberine Protects against High-Energy and Low-Protein Diet-Induced Hepatic Steatosis: Modulation of Gut Microbiota and Bile Acid Metabolism in Laying Hens.
Wang C; Yang Y; Chen J; Dai X; Xing C; Zhang C; Cao H; Guo X; Hu G; Zhuang Y
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139133
[TBL] [Abstract][Full Text] [Related]
29. The gut microbiota at the intersection of bile acids and intestinal carcinogenesis: An old story, yet mesmerizing.
Liu T; Song X; Khan S; Li Y; Guo Z; Li C; Wang S; Dong W; Liu W; Wang B; Cao H
Int J Cancer; 2020 Apr; 146(7):1780-1790. PubMed ID: 31291465
[TBL] [Abstract][Full Text] [Related]
30. Berberine alleviates cholesterol and bile acid metabolism disorders induced by high cholesterol diet in mice.
Wang Q; Shen W; Shao W; Hu H
Biochem Biophys Res Commun; 2024 Jul; 719():150088. PubMed ID: 38740003
[TBL] [Abstract][Full Text] [Related]
31. Theabrownin from Pu-erh tea attenuates hypercholesterolemia via modulation of gut microbiota and bile acid metabolism.
Huang F; Zheng X; Ma X; Jiang R; Zhou W; Zhou S; Zhang Y; Lei S; Wang S; Kuang J; Han X; Wei M; You Y; Li M; Li Y; Liang D; Liu J; Chen T; Yan C; Wei R; Rajani C; Shen C; Xie G; Bian Z; Li H; Zhao A; Jia W
Nat Commun; 2019 Oct; 10(1):4971. PubMed ID: 31672964
[TBL] [Abstract][Full Text] [Related]
32. Induction of farnesoid X receptor signaling in germ-free mice colonized with a human microbiota.
Wahlström A; Kovatcheva-Datchary P; Ståhlman M; Khan MT; Bäckhed F; Marschall HU
J Lipid Res; 2017 Feb; 58(2):412-419. PubMed ID: 27956475
[TBL] [Abstract][Full Text] [Related]
33. Hyodeoxycholic acid (HDCA) suppresses intestinal epithelial cell proliferation through FXR-PI3K/AKT pathway, accompanied by alteration of bile acids metabolism profiles induced by gut bacteria.
Song M; Yang Q; Zhang F; Chen L; Su H; Yang X; He H; Liu F; Zheng J; Ling M; Lai X; Zhu X; Wang L; Gao P; Shu G; Jiang Q; Wang S
FASEB J; 2020 May; 34(5):7103-7117. PubMed ID: 32246800
[TBL] [Abstract][Full Text] [Related]
34. Berberine treatment increases Akkermansia in the gut and improves high-fat diet-induced atherosclerosis in Apoe
Zhu L; Zhang D; Zhu H; Zhu J; Weng S; Dong L; Liu T; Hu Y; Shen X
Atherosclerosis; 2018 Jan; 268():117-126. PubMed ID: 29202334
[TBL] [Abstract][Full Text] [Related]
35. Responses of human gut microbiota abundance and amino acid metabolism
Fu Y; Wang Y; Wang X; Sun Y; Ren J; Fang B
Food Funct; 2022 Jun; 13(11):6329-6337. PubMed ID: 35611943
[TBL] [Abstract][Full Text] [Related]
36. Oral berberine improves brain dopa/dopamine levels to ameliorate Parkinson's disease by regulating gut microbiota.
Wang Y; Tong Q; Ma SR; Zhao ZX; Pan LB; Cong L; Han P; Peng R; Yu H; Lin Y; Gao TL; Shou JW; Li XY; Zhang XF; Zhang ZW; Fu J; Wen BY; Yu JB; Cao X; Jiang JD
Signal Transduct Target Ther; 2021 Feb; 6(1):77. PubMed ID: 33623004
[TBL] [Abstract][Full Text] [Related]
37. The microbiome modulating activity of bile acids.
Tian Y; Gui W; Koo I; Smith PB; Allman EL; Nichols RG; Rimal B; Cai J; Liu Q; Patterson AD
Gut Microbes; 2020 Jul; 11(4):979-996. PubMed ID: 32138583
[TBL] [Abstract][Full Text] [Related]
38. Berberine alleviates insulin resistance by reducing peripheral branched-chain amino acids.
Yue SJ; Liu J; Wang AT; Meng XT; Yang ZR; Peng C; Guan HS; Wang CY; Yan D
Am J Physiol Endocrinol Metab; 2019 Jan; 316(1):E73-E85. PubMed ID: 30422704
[TBL] [Abstract][Full Text] [Related]
39. Gut microbiota specifically mediates the anti-hypercholesterolemic effect of berberine (BBR) and facilitates to predict BBR's cholesterol-decreasing efficacy in patients.
Wu C; Zhao Y; Zhang Y; Yang Y; Su W; Yang Y; Sun L; Zhang F; Yu J; Wang Y; Guo P; Zhu B; Wu S
J Adv Res; 2022 Mar; 37():197-208. PubMed ID: 35499044
[TBL] [Abstract][Full Text] [Related]
40. Berberine, a potential prebiotic to indirectly promote Akkermansia growth through stimulating gut mucin secretion.
Dong C; Yu J; Yang Y; Zhang F; Su W; Fan Q; Wu C; Wu S
Biomed Pharmacother; 2021 Jul; 139():111595. PubMed ID: 33862492
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
